PedAM
Pediatric Disease Annotations & Medicines
| Disease | cystic fibrosis |
| Symptom | |infections |
| Sentences | 173 |
| PubMedID- 23382856 | Background: the genus burkholderia includes pathogenic gram-negative bacteria that cause melioidosis, glanders, and pulmonary infections of patients with cancer and cystic fibrosis. |
| PubMedID- 21114855 | For example, in this study, the target proteins were from p. aeruginosa, a gram negative bacterial opportunistic pathogen that causes serious lung infections in people with cystic fibrosis, and several tm proteins involved in infection were found to be expressed at sufficient levels for further study. |
| PubMedID- 21178134 | Tobramycin inhalation solution usp (tobi), a therapy developed to treat lung infections associated with cystic fibrosis (cf), was presented as a demonstration case for collaborative pharmaceutical development at a clinical and translational science awards industry forum on "promoting efficient and effective collaborations among academia, government, and industry" held in february 2010. |
| PubMedID- 24633206 | Chelonae infections, including those with underlying cystic fibrosis, despite failure of prior antibiotic therapy. |
| PubMedID- 26313907 | The feoabc system is active during infections in patients with cystic fibrosis . |
| PubMedID- 22940004 | There is clear evidence some viral infections are associated with cystic fibrosis that dual infection is more likely to produce symptoms, and mechanisms of viral-induced exacerbation should be elucidated. |
| PubMedID- 24039595 | Pseudomonas aeruginosa is the dominating pathogen of chronic airway infections in patients with cystic fibrosis (cf). |
| PubMedID- 20729192 | The type vi secretion system (t6ss) contributes to the virulence of burkholderia cenocepacia, an opportunistic pathogen causing serious chronic infections in patients with cystic fibrosis. |
| PubMedID- 25590621 | These results highlight a dynamic bacterial-host interaction between an opportunistic pathogen that causes chronic infections in the lungs of individuals with cystic fibrosis, an infection site known to be rich in neutrophil dna and neutrophil extracellular traps . |
| PubMedID- 25861381 | 2011), and even in chronic lung infections such as that of cystic fibrosis (konstan et al. |
| PubMedID- 25417708 | Aeruginosa infections among patients with cystic fibrosis. |
| PubMedID- 21995705 | Bcc bacteria emerged in the 1980s as opportunistic human pathogens responsible for devastating lung infections in people with cystic fibrosis and chronic granulomatous disease 3. |
| PubMedID- 21781329 | Background: burkholderia cenocepacia is a member of the burkholderia cepacia complex group of bacteria that cause infections in individuals with cystic fibrosis. |
| PubMedID- 24201191 | Mycobacterium abscessus is a rapidly growing mycobacterium and an emerging human pathogen causing pulmonary infections, especially in patients with cystic fibrosis and other underlying lung disorders (1). |
| PubMedID- 25147668 | One of the most medically important biofilm-forming species is pseudomonas aeruginosa, which is commonly associated with lung infections in patients with cystic fibrosis. |
| PubMedID- 24370741 | A new study uses whole-genome and population sequencing approaches to identify evidence of adaptive evolution in burkholderia dolosa genomes isolated from chronic infections in patients with cystic fibrosis. |
| PubMedID- 25488299 | Pseudomonas aeruginosa is an opportunistic human pathogen and a major cause of chronic infections in individuals with cystic fibrosis (cf). |
| PubMedID- 22309106 | The opportunistic pathogen pseudomonas aeruginosa causes life-threatening, persistent infections in patients with cystic fibrosis (cf). |
| PubMedID- 24136845 | Pseudomonas aeruginosa frequently establishes chronic infections in the airways of patients suffering from cystic fibrosis (cf). |
| PubMedID- 23658631 | It is particularly prominent as a pathogen in broncho-pulmonary infections in patients with cystic fibrosis and chronic lung disorders . |
| PubMedID- 22848588 | Burkholderia cepacia complex (bcc) bacteria are a problematic group of microorganisms causing severe infections in patients with cystic fibrosis. |
| PubMedID- 22069491 | Pseudomonas aeruginosa is an opportunistic pathogen that causes both acute pneumonitis in immunocompromised patients and chronic lung infections in individuals with cystic fibrosis and other bronchiectasis. |
| PubMedID- 22919658 | Burkholderia cepacia complex (bcc) bacteria can cause devastating chronic infections in people with cystic fibrosis. |
| PubMedID- 20732993 | Aeruginosa and for understanding the role that innate immune cells, such as neutrophils, play in the host response to acute bacterial infections commonly associated with cystic fibrosis. |
| PubMedID- 24034668 | It is responsible for serious chronic and often fatal lung infections in patients with cystic fibrosis and acute infections in patients that are immune compromised or have serious burns 1. |
| PubMedID- 24526633 | The bcc have the potential to cause chronic and severe airway infections in persons with cystic fibrosis (cf) (2). |
| PubMedID- 21949654 | However, how bacteria establish chronic infections, as observed in patients with cystic fibrosis (cf), and the reasons that these infective agents cannot be eliminated by the immune system are still largely unclear . |
| PubMedID- 23305366 | This group of pathogens are responsible for chronic lung infections in people with cystic fibrosis and other immunocompromised individuals. |
| PubMedID- 26505731 | We identify markers of coordinated initial signaling in macrophages challenged with ligands to prrs of the toll-like receptor (tlr) family and compare this response to that induced by intact bacteria of the burkholderia cenocepacia complex (bcc), an opportunistic pathogen that causes life-threatening infections in patients with cystic fibrosis and chronic granulomatous disease. |
| PubMedID- 25470304 | Objectives: the objective of our review was to compare antibiotic treatment to no antibiotic treatment, or to compare different combinations of antibiotic treatment, for nontuberculous mycobacteria lung infections in people with cystic fibrosis. |
| PubMedID- 21811611 | Burkholderia cenocepacia is an important opportunistic pathogen causing respiratory infections in individuals with cystic fibrosis (cf). |
| PubMedID- 23272096 | Burn wound infections, pneumonia, infections in patients with cystic fibrosis, intra-abdominal infections, chronic ulcers, and sepsis 6. |
| PubMedID- 20934258 | Pseudomonas aeruginosa is the major pathogen of chronic lung infections in individuals with cystic fibrosis (cf). |
| PubMedID- 21067332 | Furthermore, we examine the epidemiologic studies of candida albicans, exophiala dermatitidis and scedosporium apiospermum infections in patients with cystic fibrosis. |
| PubMedID- 24637508 | Aeruginosa is an opportunistic bacterial pathogen which establishes chronic pulmonary infections in patients with cystic fibrosis (cf). |
| PubMedID- 22968160 | Fluoroquinolones are commonly used to treat lung infections in patients with cystic fibrosis. |
| PubMedID- 22150831 | Burkholderia cepacia complex (bcc) bacteria are opportunistic pathogens that cause multiresistant pulmonary infections in patients with cystic fibrosis (cf). |
| PubMedID- 22679547 | Patients who have end stage lung diseases such as cystic fibrosis, bronchiectasia along with secondary lung infections need lung transplantation to prolong their life. |
| PubMedID- 26356298 | A group of 17 closely related species, designated b. cepacia complex organisms, cause pulmonary infections primarily in patients with cystic fibrosis . |
| PubMedID- 24060984 | Purpose of review: this review summarizes some of the important recent findings concerning fungal airway infections in patients with cystic fibrosis (cf). |
| PubMedID- 20137066 | Background: burkholderia cepacia complex bacteria are opportunistic pathogens, which can cause severe respiratory tract infections in patients with cystic fibrosis (cf). |
| PubMedID- 21811795 | Another similarity is the alginate production in a. vinelandii, which is also a by-product in pathogenic p. aeruginosa infections in the lungs of cystic fibrosis patients . |
| PubMedID- 25445528 | Sodium colistimethate loaded lipid nanocarriers for the treatment of pseudomonas aeruginosa infections associated with cystic fibrosis. |
| PubMedID- 24393536 | Members of the burkholderia cepacia complex (bcc) can cause severe respiratory infections in individuals with cystic fibrosis (cf) 1. |
| PubMedID- 19889907 | Burkholderia cenocepacia can cause serious infections and epidemics in patients with cystic fibrosis (cf). |
| PubMedID- 20625718 | Aeruginosa even in mature biofilms and cationic steroid antibiotics can thus be considered as potential candidates for the treatment of chronic pulmonary infections of patients with cystic fibrosis. |
| PubMedID- 26360059 | It often causes opportunistic infections in hospitalized patients of cystic fibrosis and burn victim who are immunosuppressed or immunocompromised . |
| PubMedID- 24223216 | Members of the burkholderia cepacia complex (bcc) have emerged in recent decades as problematic pulmonary pathogens of cystic fibrosis (cf) patients, with severe infections progressing to acute necrotizing pneumonia and sepsis. |
| PubMedID- 22767545 | Burkholderia cenocepacia is a member of the burkholderia cepacia complex (bcc), a group of gram-negative opportunistic pathogens that cause severe lung infections in patients with cystic fibrosis and display extreme intrinsic resistance to antibiotics, including antimicrobial peptides. |
| PubMedID- 21395432 | Abstract at present, the only approved inhaled antipseudomonal antibiotics for chronic pulmonary infections in patients with cystic fibrosis (cf) are nebulized solutions. |